NKVO Exchange Successfully Participates in the 2024 TOKEN2049 Conference in Singapore, Exploring the Future of the Decrypt and Blockchain Industry

On September 20, NKVO Exchange announced its successful participation in the 2024 TOKEN2049 Conference held in Singapore. This premier global event attracted numerous leading companies, investors, and professionals from the cryptocurrency industry. At the conference, NKVO actively engaged in discussions about the future development of decentralization, cryptocurrency, and blockchain technology, fostering in-depth dialogues with decision-makers in the global blockchain sector and further enhancing its influence within the cryptocurrency ecosystem.

TOKEN2049, recognized as one of the most influential cryptocurrency ecosystem conferences worldwide, took place from September 18 to 19. The Singapore edition drew over 20,000 attendees, including representatives from more than 150 countries and over 7,000 companies. During the event, NKVO Exchange explored future development paths for decentralized blockchain applications and cryptocurrency technologies through exchanges with multiple leading global enterprises and industry experts, showcasing its robust capabilities in this field.

Throughout the TOKEN2049 conference, NKVO representatives participated in several roundtable discussions, focusing on innovations and applications of blockchain technology. As a rapidly rising exchange platform, NKVO holds the necessary qualifications, including a U.S. MSB license and is in the process of applying for a Canadian MSB license. The exchange is committed to providing global users with secure, transparent, and efficient cryptocurrency trading services. During the conference, NKVO also shared its plans for expanding into the South Asian market, particularly Singapore, receiving widespread praise for its efficient trading mechanisms and user-friendly interface.

In a keynote speech, NKVO’s CEO stated, “Participating in TOKEN2049 is a significant step in NKVO’s development strategy. This conference not only allowed us to engage deeply with industry leaders on the future of global blockchain technology but also showcased potential development directions for new technologies. NKVO will continue to focus on the research and development of decentralized technologies, promoting innovative application scenarios to help global users better engage with the cryptocurrency ecosystem.”

NKVO’s successful involvement in the TOKEN2049 conference marks a significant step in its ascent within the global blockchain industry. Through extensive interactions with other industry leaders, NKVO has enhanced its insights into global market trends and expanded its strategic partnerships with international collaborators. This solid foundation paves the way for NKVO’s future international development while providing users with more diverse service options.

Looking ahead, NKVO Exchange will actively participate in similar global conferences, dedicated to promoting the further advancement of cryptocurrency and blockchain technology while continually improving its ecosystem. Although the TOKEN2049 Singapore conference has concluded, NKVO’s journey of global expansion is just beginning.

Disclaimer: This press release may contain forward-looking statements. Forward-looking statements describe future expectations, plans, results, or strategies (including product offerings, regulatory plans and business plans) and may change without notice. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements.

Media Contact
Company Name: NKVO
Contact Person: Lucy Jones
Email: Send Email
Country: Singapore
Website: https://nkvo.com/

Filmmakers Reignite Interest in Lake Champlain’s Legendary Lake Monster with Drone Footage and Upcoming Film Screenings

Filmmakers Reignite Interest in Lake Champlain’s Legendary Lake Monster with Drone Footage and Upcoming Film Screenings

Filmmakers Kelly Tabor and Richard Rossi at Lake Champlain, sharing their excitement over capturing drone footage of the legendary lake monster “Champ,” and announcing upcoming screenings of their film “Lucy and the Lake Monster”
Behind the Lens: Movie Makers Kelly Tabor & Richard Rossi’s Journey from Myth to Film

Following last month’s sensational capturing of footage featuring the elusive Loch Ness-like creature known as “Champ” in Lake Champlain, filmmakers Kelly Tabor and Richard Rossi are thrilled to invite the public to rekindle their fascination with this legendary lake monster. Their captivating drone footage, shared on YouTube, continues to enchant viewers and prompt discussions about the enduring myth and mystery surrounding Champ.

With over 34,000 views since its release, the footage showcases an aerial view of the lake, revealing an intriguing glimpse of a large creature in the bottom right of the screen, swimming behind a boat containing the two lead actors in their fictional Champ movie. The found footage of Champ captured inadvertently, has intrigued and inspired believers and skeptics alike. The video has sparked a renewed interest in Lake Champlain’s folklore and the quest to uncover the truth about its most famous inhabitant—Champ.

“We are amazed by the public’s reaction to our footage,” said Richard Rossi. “It’s thrilling to see so many people engaged in the mystery and lore of Champ.”

“I’ve looked for Champ for over fifty years,” Kelly Tabor said.  “This is a highlight of my life, to finally capture footage of Champ.  This legendary creature has a special place in the hearts of many, and we hope our footage ignites even more conversations.”

In tandem with this renewed excitement, Rossi and Tabor are proud to announce screenings of their fictional adventure film, “Lucy and the Lake Monster.” The film, which weaves a delightful narrative around the tale of Champ, will screen in Hawthorne, New Jersey on October 13th and in Buffalo, New York on October 19th. This family-friendly movie promises to charm audiences of all ages as it merges the realms of myth and adventure.

“Lucy and the Lake Monster” not only highlights the legend of Champ but also reflects the magic of believing in the extraordinary, making it a fitting companion to our footage,” said Kelly Tabor. “We can’t wait to share the film with audiences and continue exploring this captivating legend together.”

The public is encouraged to revisit the YouTube video here featuring Champ’s drone Tabor-Rossi footage and share their thoughts, theories, and experiences related to Lake Champlain. Join the conversation and be part of a legacy that has fascinated generations.

For more details about the screenings of “Lucy and the Lake Monster,” and ticket information, please visit https://www.lucyandthelakemonster.com.

Media Contact
Company Name: Lucy & the Lake Monster
Contact Person: Kelly Tabor & Richard Rossi, Filmmakers
Email: Send Email
Phone: 1 310 276 2251
City: Lake Champlain
State: New York
Country: United States
Website: https://www.lucyandthelakemonster.com

Vernal Keratoconjunctivitis Market to Show Remarkable Growth Trends from 2024 to 2034, DelveInsight Reports | Santen SAS, Novartis, Laboratoires Thea, Allakos Inc., Santen SASl, Astellas Pharma Inc

The Key Vernal Keratoconjunctivitis Companies in the market include – Santen Pharmaceutical, Novartis, Laboratoires Thea, Allakos Inc., Santen SASl, Astellas Pharma Inc, and others.

 

DelveInsight’s “Vernal Keratoconjunctivitis Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Vernal Keratoconjunctivitis, historical and forecasted epidemiology as well as the Vernal Keratoconjunctivitis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

 

To Know in detail about the Vernal Keratoconjunctivitis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Vernal Keratoconjunctivitis Market Forecast

 

Some of the key facts of the Vernal Keratoconjunctivitis Market Report: 

  • The Vernal Keratoconjunctivitis market size is anticipated to grow with a significant CAGR during the study period (2020-2034)

  • The prevalence of VKC in Italy is reported to range from 2.4% to 27.8%.

  • In France, the prevalence of VKC was estimated to be roughly between 0.7% and 3.3%.

  • It was observed that VKC is more common in males than in females.

  • According to the analysis, most VKC cases occur in patients aged 0 to 20 years, with the onset typically between 10 and 12 years. However, there have been reports of cases in patients as young as 5 months.

  • Key Vernal Keratoconjunctivitis Companies: Santen Pharmaceutical, Novartis, Laboratoires Thea, Allakos Inc., Santen SASl, Astellas Pharma Inc, and others

  • Key Vernal Keratoconjunctivitis Therapies: VERKAZIA (Cyclosporine Ophthalmic Emulsion), NOVA22007 ”Ciclosporin”, Cyclosporine A, N-acetyl-aspartyl-glutamate (NAAXIA Sine), AK002, Cyclosporine NOVA22007, FK506, and others

  • The Vernal Keratoconjunctivitis market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Vernal Keratoconjunctivitis pipeline products will significantly revolutionize the Vernal Keratoconjunctivitis market dynamics.

 

Vernal Keratoconjunctivitis Overview

Young, males are most frequently affected by vernal keratoconjunctivitis (VKC), a persistent allergic conjunctivitis. Even while the majority of allergic conjunctivitis types do not impair vision, VKC is uncommon in that it can cause vision loss if the cornea is damaged.

 

Get a Free sample for the Vernal Keratoconjunctivitis Market Report:

https://www.delveinsight.com/report-store/vernal-keratoconjunctivitis-market-insight

 

Vernal Keratoconjunctivitis Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

 

Vernal Keratoconjunctivitis Epidemiology Segmentation:

The Vernal Keratoconjunctivitis market report proffers epidemiological analysis for the study period 2020–2034 in the 7MM segmented into:

  • Total Prevalence of Vernal Keratoconjunctivitis

  • Prevalent Cases of Vernal Keratoconjunctivitis by severity

  • Gender-specific Prevalence of Vernal Keratoconjunctivitis

  • Diagnosed Cases of Episodic and Chronic Vernal Keratoconjunctivitis

 

Download the report to understand which factors are driving Vernal Keratoconjunctivitis epidemiology trends @ Vernal Keratoconjunctivitis Epidemiology Forecast

 

Vernal Keratoconjunctivitis Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Vernal Keratoconjunctivitis market or expected to get launched during the study period. The analysis covers Vernal Keratoconjunctivitis market uptake by drugs, patient uptake by therapies, and sales of each drug. 

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Vernal Keratoconjunctivitis Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

 

Vernal Keratoconjunctivitis Therapies and Key Companies

  • VERKAZIA (Cyclosporine Ophthalmic Emulsion): Santen Pharmaceutical

  • NOVA22007 ”Ciclosporin”: Santen SAS

  • Cyclosporine A: Novartis

  • N-acetyl-aspartyl-glutamate (NAAXIA Sine): Laboratoires Thea

  • AK002: Allakos Inc.

  • Cyclosporine NOVA22007: Santen SAS

  • FK506: Astellas Pharma Inc

 

Discover more about therapies set to grab major Vernal Keratoconjunctivitis market share @ Vernal Keratoconjunctivitis Treatment Market

 

Scope of the Vernal Keratoconjunctivitis Market Report

  • Study Period: 2020–2034

  • Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]

  • Key Vernal Keratoconjunctivitis Companies: Santen Pharmaceutical, Novartis, Laboratoires Thea, Allakos Inc., Santen SASl, Astellas Pharma Inc, and others

  • Key Vernal Keratoconjunctivitis Therapies: VERKAZIA (Cyclosporine Ophthalmic Emulsion), NOVA22007 ”Ciclosporin”, Cyclosporine A, N-acetyl-aspartyl-glutamate (NAAXIA Sine), AK002, Cyclosporine NOVA22007, FK506, and others

  • Vernal Keratoconjunctivitis Therapeutic Assessment: Vernal Keratoconjunctivitis current marketed and Vernal Keratoconjunctivitis emerging therapies

  • Vernal Keratoconjunctivitis Market Dynamics: Vernal Keratoconjunctivitis market drivers and Vernal Keratoconjunctivitis market barriers 

  • Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies

  • Vernal Keratoconjunctivitis Unmet Needs, KOL’s views, Analyst’s views, Vernal Keratoconjunctivitis Market Access and Reimbursement 

 

To know more about Vernal Keratoconjunctivitis companies working in the treatment market, visit @ Vernal Keratoconjunctivitis Clinical Trials and Therapeutic Assessment

 

Table of Contents 

1. Vernal Keratoconjunctivitis Market Report Introduction

2. Executive Summary for Vernal Keratoconjunctivitis

3. SWOT analysis of Vernal Keratoconjunctivitis

4. Vernal Keratoconjunctivitis Patient Share (%) Overview at a Glance

5. Vernal Keratoconjunctivitis Market Overview at a Glance

6. Vernal Keratoconjunctivitis Disease Background and Overview

7. Vernal Keratoconjunctivitis Epidemiology and Patient Population

8. Country-Specific Patient Population of Vernal Keratoconjunctivitis 

9. Vernal Keratoconjunctivitis Current Treatment and Medical Practices

10. Vernal Keratoconjunctivitis Unmet Needs

11. Vernal Keratoconjunctivitis Emerging Therapies

12. Vernal Keratoconjunctivitis Market Outlook

13. Country-Wise Vernal Keratoconjunctivitis Market Analysis (2020–2034)

14. Vernal Keratoconjunctivitis Market Access and Reimbursement of Therapies

15. Vernal Keratoconjunctivitis Market Drivers

16. Vernal Keratoconjunctivitis Market Barriers

17.  Vernal Keratoconjunctivitis Appendix

18. Vernal Keratoconjunctivitis Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

 

About DelveInsight 

DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Vernal Keratoconjunctivitis Market to Show Remarkable Growth Trends from 2024 to 2034, DelveInsight Reports | Santen SAS, Novartis, Laboratoires Thea, Allakos Inc., Santen SASl, Astellas Pharma Inc

Severe Hypertriglyceridemia Market Growth to Accelerate in Forecast Period (2024-2034), DelveInsight Analyzes | Ionis Pharma, 89bio, Inc., Arrowhead Pharma, Hightide Therapeutics, AstraZeneca, Kowa

The Key Severe Hypertriglyceridemia Companies in the market include – Amarin Corporation, Ionis Pharmaceuticals, 89bio, Inc., Arrowhead Pharmaceuticals, Inc., Hightide Therapeutics, AstraZeneca, Kowa Research Institute, Inc., Regeneron Pharmaceuticals, Mochida Pharmaceutical, NeuroBo Pharma, Arisaph Pharma, Acasti Pharma Inc., and others.

 

DelveInsight’s “Severe Hypertriglyceridemia Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Severe Hypertriglyceridemia, historical and forecasted epidemiology as well as the Severe Hypertriglyceridemia market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

 

To Know in detail about the Severe Hypertriglyceridemia market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Severe Hypertriglyceridemia Market Forecast

 

Some of the key facts of the Severe Hypertriglyceridemia Market Report: 

  • The Severe Hypertriglyceridemia market size was valued approximately ~USD 2,421 million in 2023 and is anticipated to grow with a significant CAGR during the study period (2020-2034)

  • In 2023, the United States held the largest market share for severe hypertriglyceridemia, comprising about 58% of the total market size in the 7MM, in comparison to other key markets, including the EU4 countries (Germany, France, Italy, and Spain), the United Kingdom, and Japan.

  • In 2023, Germany recorded the largest market size for severe hypertriglyceridemia among European countries, reaching approximately USD 180 million, whereas Spain had the smallest market size at around USD 100 million.

  • In 2023, the market size for severe hypertriglyceridemia in Japan was estimated at approximately USD 324 million, representing 13% of the total market across the 7MM.

  • The anticipated introduction of new therapies, including ARO-APOC3, is expected to impact the overall market size of severe hypertriglyceridemia in the coming years.

  • In 2023, the total number of prevalent cases of Hypertriglyceridemia in the 7MM was 155 million, and this figure is anticipated to increase by 2034.

  • The United States had the highest diagnosed prevalence of Hypertriglyceridemia among the 7MM countries. According to DelveInsight’s estimates, it accounts for approximately 44% of the total diagnosed prevalent cases of hypertriglyceridemia in the 7MM.

  • In 2023, the diagnosed prevalent cases of Severe Hypertriglyceridemia (SHTG) in the 7MM were approximately 3,495 thousand, with expectations for an increase during the forecast period.

  • In 2023, Germany reported the highest number of diagnosed prevalent cases of Hypertriglyceridemia among European countries, with approximately 7 million cases, followed by the UK. Conversely, Spain had the lowest prevalence, with around 4 million cases.

  • In 2023, within the 7MM, severe hypertriglyceridemia cases were classified by etiology. The diagnosed prevalent cases of primary and secondary severe hypertriglyceridemia were approximately 1,500 thousand and 1,980 thousand, respectively.

  • In 2023, the EU4 and the UK reported approximately 1,388 thousand diagnosed prevalent cases of severe hypertriglyceridemia. Among these, Germany accounted for about 364 thousand cases, representing the highest number of diagnosed prevalent cases of severe hypertriglyceridemia in Europe.

  • In 2023, Japan represented 16% of the total diagnosed prevalent cases of severe hypertriglyceridemia in the 7MM, with around 562 thousand cases.

  • Key Severe Hypertriglyceridemia Companies: Amarin Corporation, Ionis Pharmaceuticals, 89bio, Inc., Arrowhead Pharmaceuticals, Inc., Hightide Therapeutics, AstraZeneca, Kowa Research Institute, Inc., Regeneron Pharmaceuticals, Mochida Pharmaceutical, NeuroBo Pharma, Arisaph Pharma, Acasti Pharma Inc., and others

  • Key Severe Hypertriglyceridemia Therapies: VASCEPA/VAZKEPA, Plozasiran (ARO-APOC3), Olezarsen, Pegozafermin (BIO89-100), ARO-APOC3, HTD1801, omefas, K-877, evinacumab, Ethyl Icosapentate, Gemcabene, ARI-3037MO, CaPre, Epanova, and others

  • The Severe Hypertriglyceridemia epidemiology based on gender analyzed that the severity‐specific data reveal the highest number of cases were observed in moderate level of HTG

  • The Severe Hypertriglyceridemia market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Severe Hypertriglyceridemia pipeline products will significantly revolutionize the Severe Hypertriglyceridemia market dynamics.

 

Severe Hypertriglyceridemia Overview

Primary illnesses and secondary disorders are the two basic categories into which severe hypertriglyceridemia falls. Genetic illnesses fall under the category of main disorders, with secondary causes and other underlying conditions frequently contributing to the latter.

 

Get a Free sample for the Severe Hypertriglyceridemia Market Report:

https://www.delveinsight.com/report-store/severe-hypertriglyceridemia-shtg-market

 

Severe Hypertriglyceridemia Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

 

Severe Hypertriglyceridemia Epidemiology Segmentation:

The Severe Hypertriglyceridemia market report proffers epidemiological analysis for the study period 2020–2034 in the 7MM segmented into:

  • Total Prevalence of Severe Hypertriglyceridemia

  • Prevalent Cases of Severe Hypertriglyceridemia by severity

  • Gender-specific Prevalence of Severe Hypertriglyceridemia

  • Diagnosed Cases of Episodic and Chronic Severe Hypertriglyceridemia

 

Download the report to understand which factors are driving Severe Hypertriglyceridemia epidemiology trends @ Severe Hypertriglyceridemia Epidemiology Forecast

 

Severe Hypertriglyceridemia Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Severe Hypertriglyceridemia market or expected to get launched during the study period. The analysis covers Severe Hypertriglyceridemia market uptake by drugs, patient uptake by therapies, and sales of each drug. 

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Severe Hypertriglyceridemia Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

 

Severe Hypertriglyceridemia Therapies and Key Companies

  • VASCEPA/VAZKEPA: Amarin Corporation

  • Plozasiran (ARO-APOC3): Arrowhead Pharmaceuticals, Inc.

  • Olezarsen: Ionis Pharmaceuticals

  • Pegozafermin (BIO89-100): 89bio, Inc.

  • ARO-APOC3: Arrowhead Pharmaceuticals, Inc.

  • HTD1801: HightideTherapeutics

  • omefas: AstraZeneca

  • K-877: Kowa Research Institute, Inc.

  • evinacumab: Regeneron Pharmaceuticals

  • Ethyl Icosapentate: Mochida Pharmaceutical

  • Gemcabene: NeuroBo Pharma

  • ARI-3037MO: Arisaph Pharma

  • CaPre: Acasti Pharma Inc.

  • Epanova: AstraZeneca

 

Discover more about therapies set to grab major Severe Hypertriglyceridemia market share @ Severe Hypertriglyceridemia Treatment Market

 

Severe Hypertriglyceridemia Market Strengths

  • The increasing prevalent population and increasing episodes of primary and secondary causes worldwide are likely to cause a surge in treatment options. Consequently, the market will witness a boost in the upcoming year

 

Severe Hypertriglyceridemia Market Opportunities

  • Medications with better safety and effectiveness, which provide an optimum cure, are the current unmet need of the SHTG disease market.

 

Scope of the Severe Hypertriglyceridemia Market Report

  • Study Period: 2020–2034

  • Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]

  • Key Severe Hypertriglyceridemia Companies: Amarin Corporation, Ionis Pharmaceuticals, 89bio, Inc., Arrowhead Pharmaceuticals, Inc., Hightide Therapeutics, AstraZeneca, Kowa Research Institute, Inc., Regeneron Pharmaceuticals, Mochida Pharmaceutical, NeuroBo Pharma, Arisaph Pharma, Acasti Pharma Inc., and others

  • Key Severe Hypertriglyceridemia Therapies: VASCEPA/VAZKEPA, Plozasiran (ARO-APOC3), Olezarsen, Pegozafermin (BIO89-100), ARO-APOC3, HTD1801, omefas, K-877, evinacumab, Ethyl Icosapentate, Gemcabene, ARI-3037MO, CaPre, Epanova, and others

  • Severe Hypertriglyceridemia Therapeutic Assessment: Severe Hypertriglyceridemia current marketed and Severe Hypertriglyceridemia emerging therapies

  • Severe Hypertriglyceridemia Market Dynamics: Severe Hypertriglyceridemia market drivers and Severe Hypertriglyceridemia market barriers 

  • Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies

  • Severe Hypertriglyceridemia Unmet Needs, KOL’s views, Analyst’s views, Severe Hypertriglyceridemia Market Access and Reimbursement 

 

To know more about Severe Hypertriglyceridemia companies working in the treatment market, visit @ Severe Hypertriglyceridemia Clinical Trials and Therapeutic Assessment

 

Table of Contents 

1. Severe Hypertriglyceridemia Market Report Introduction

2. Executive Summary for Severe Hypertriglyceridemia

3. SWOT analysis of Severe Hypertriglyceridemia

4. Severe Hypertriglyceridemia Patient Share (%) Overview at a Glance

5. Severe Hypertriglyceridemia Market Overview at a Glance

6. Severe Hypertriglyceridemia Disease Background and Overview

7. Severe Hypertriglyceridemia Epidemiology and Patient Population

8. Country-Specific Patient Population of Severe Hypertriglyceridemia 

9. Severe Hypertriglyceridemia Current Treatment and Medical Practices

10. Severe Hypertriglyceridemia Unmet Needs

11. Severe Hypertriglyceridemia Emerging Therapies

12. Severe Hypertriglyceridemia Market Outlook

13. Country-Wise Severe Hypertriglyceridemia Market Analysis (2020–2034)

14. Severe Hypertriglyceridemia Market Access and Reimbursement of Therapies

15. Severe Hypertriglyceridemia Market Drivers

16. Severe Hypertriglyceridemia Market Barriers

17.  Severe Hypertriglyceridemia Appendix

18. Severe Hypertriglyceridemia Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

 

About DelveInsight 

DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Severe Hypertriglyceridemia Market Growth to Accelerate in Forecast Period (2024-2034), DelveInsight Analyzes | Ionis Pharma, 89bio, Inc., Arrowhead Pharma, Hightide Therapeutics, AstraZeneca, Kowa

Metal Roofing Indianapolis Sets the Standard for Roofing with Premium Residential and Commercial Solutions

Metal Roofing Indianapolis Sets the Standard for Roofing with Premium Residential and Commercial Solutions
Metal Roofing Indianapolis sets the standard for durable, energy-efficient roofing solutions, offering expert metal and commercial roofing services across the Indianapolis area.

Trusted for its reliable residential and commercial roofing services in the Indianapolis area, Metal Roofing Indianapolis has built its reputation on exceptional craftsmanship and customer satisfaction, bringing extensive knowledge and experience to offer a full range of roofing services, including inspections, repairs, and replacements. 

Metal Roofing Indianapolis provides complete roofing solutions for homeowners and business owners in Indianapolis, from installations, inspections, maintenance, and replacements to repairs, coatings, restorations, and rejuvenations. As a full-service company, it also provides emergency repairs, guttering, skylights, and attic venting services, ensuring customers receive the most suitable and cost-effective solutions.

A leading contractor for commercial roofing in Indianapolis, the company specializes in installing and maintaining metal roofing systems renowned for their longevity, durability, and energy efficiency, making them a popular choice for homeowners and businesses in Indianapolis. The company handles projects of all sizes, from minor repairs to large-scale installations, ensuring each roof is maintained in top condition.

One of the primary benefits of metal roofing is its resilience against harsh weather conditions. Indianapolis experiences a wide range of weather patterns, from heavy snowfall to intense heat, and metal roofs are specifically designed to withstand these challenges. The material’s resistance to corrosion, fire, and wind ensures that properties remain protected for decades, minimizing the need for frequent repairs or replacements. 

For more information, visit https://www.metalroofingindianapolis.net/commercial-roofing/

Beyond its metal roofing services, Metal Roofing Indianapolis is highly regarded for its expertise in various roofing projects. Whether dealing with flat roofs, TPO roofing, or modified bitumen systems, the company uses high-quality materials and advanced installation techniques for durability and energy efficiency, reducing energy costs while ensuring buildings remain structurally sound. 

Metal Roofing Indianapolis takes pride in offering customized roofing solutions that meet the specific needs of each business. The team works closely with clients to understand their goals, from enhancing energy performance to addressing maintenance issues or upgrading an old roof to a more modern and sustainable system.

Several factors distinguish Metal Roofing Indianapolis from its competitors in the roofing industry. A team of highly skilled professionals with years of experience in metal and commercial roofing enables the company to tackle complex projects with precision and efficiency, delivering superior results every time.

Customer satisfaction is at the core of its operations. Every project begins with a thorough consultation to assess and provide clients with a tailored roofing solution. From the initial quote to the final inspection, clients are regularly informed of progress, ensuring transparency and trust.

Metal Roofing Indianapolis continually updates its methods and techniques to stay at the forefront of roofing technology. Adopting the latest advancements in roofing materials and installation processes ensures each project benefits from the best available practices in the industry.

Whether dealing with a metal roof installation or a commercial roof upgrade, the company delivers solutions that offer long-term value. Each project is executed with meticulous attention to detail, ensuring the final result meets a high standard of quality and durability.

Metal Roofing Indianapolis has earned its reputation as a leading provider of metal roofing Indianapolis and commercial roofing Indianapolis services. Offering high-quality materials, expert installation, and a customer-centric approach, the company continues to set the bar for excellence in roofing. With a commitment to durability, innovation, and eco-friendly practices, Metal Roofing Indianapolis is the trusted partner for all roofing needs in the Indianapolis area.

About the Company:

Metal Roofing Indianapolis is a trusted name in roofing solutions, specializing in metal and commercial roofing services throughout the Indianapolis area. The company offers expert installation, repair, and maintenance for residential and commercial properties, using high-quality materials that ensure durability and long-lasting performance. Known for its skilled craftsmanship, Metal Roofing Indianapolis is committed to delivering customized roofing solutions tailored to the unique needs of each project. With a focus on energy efficiency, sustainability, and customer satisfaction, the company continues to be a leader in the roofing industry in Indianapolis.

Media Contact
Company Name: Metal Roofing Indianapolis
Contact Person: Cody K
Email: Send Email
Phone: +1 (463) 231-3049
Address:4826 W 34th St
City: Indianapolis
State: IN 46224
Country: United States
Website: https://www.metalroofingindianapolis.net/

Summit Delivery Services’ Donald Staniszewski Launches Transformative New Book, “Leap Beyond Your Limits”

NASHVILLE, TENNESSEE – September 30, 2024 – Summit Delivery Services’ President and best selling author Donald Staniszewski is excited to announce the official launch of his groundbreaking new book, “Leap Beyond Your Limits: Conquer Fear to Triumph in Life and Leadership.” Donald Staniszewski is also the Chairman of the National Home Delivery Association Foundation. This Kindle Edition already has a five-star rating on Amazon. Readers can discover a compelling road map that helps them overcome their deepest fears to achieve success in their lives and careers.

Image Credits: Leap Beyond Your Limits by Donald Staniszewski

In “Leap Beyond Your Limits,” Staniszewski shares his personal life story, from facing challenges at a very young age to handling complex psychological obstacles in his leadership roles. Combining provoking insights with practical tips, this work explores fear as a major obstacle to success and lays out clear strategies to turn this obstacle into a powerful motivator. By being open about his life experiences, Staniszewski helps readers identify how to overcome their fears; thus, massive growth can be fostered in their professional and personal lives.

The book is a comprehensive resource on understanding and overcoming fear, with actionable strategies for turning it into a force for positive change. Staniszewski teaches readers how to identify their fears and confront them head-on, use positive thinking to get themselves ahead, and set realistic, attainable goals. Each chapter provides practical tools and techniques to foster resilience and persistence in the face of adversity.

Apart from being a guide, “Leap Beyond Your Limits” is a call to action for anyone with personal doubts or work challenges. Staniszewski’s way of thinking encourages readers to adopt a mindset that builds courage, resilience, and a desire to lead by example. Whether facing self-doubt or trying to make a real impact, readers will find helpful lessons and inspiration within its pages.

With his extensive leadership experience and personal insights, Staniszewski presents a book that is both motivational and practical. Leap Beyond Your Limits highlights the author’s dedication to helping others realize their potential. This book is an essential read for anyone ready to conquer their fears and achieve their fullest potential. 

About Donald Staniszewski

Donald Staniszewski is a distinguished leader in the field of home delivery and logistics and is currently serving as Chairman of the National Home Delivery Association Foundation and President of Summit Delivery Services. His new book, Leap Beyond Your Limits: Conquer Fear to Triumph in Life and Leadership, mirrors his commitment to helping individuals break through barriers and reach their highest potential.

Media Contact
Company Name: Summit Delivery Services
Contact Person: Donald Staniszewski
Email: Send Email
City: Nashville
State: Tennessee
Country: United States
Website: https://summitdeliveryservices.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Summit Delivery Services’ Donald Staniszewski Launches Transformative New Book, “Leap Beyond Your Limits”

SmartAC.com Launches New App-Only Offering to Maximize Customer Retention

“SmartAC.com launches new app-only offering to maximize customer retention”

Houston, TX – Sep 30, 2024 – SmartAC.com is proud to introduce its innovative “Connect” offer, designed to give contractors a way to stay connected to homeowners who decline to sign up for service agreements.  The new app-only service offers many of the key benefits of the SmartAC.com software platform, while incorporating some new features to empower contractors to foster lasting relationships with the great majority of homeowners who historically haven’t been willing to commit to a full membership. 

The “Connect” offering is an extension of SmartAC.com’s mission to make home comfort simple and proactive. With it, they’re launching two new features to bolster the app’s value. Homeowners will now be able to integrate their smart thermostats to get high-level insights and alerts on their HVAC performance. Also, the new chat and video call features allow customers to immediately connect with contractors, in whatever way they choose, to get fast feedback on the best plan of action for any issue they’re having at their home. 

“Our north star is to help contractors acquire an ongoing relationship in 90% of first-time customer interactions,” said Josh Teekell, CEO of SmartAC.com. “To accomplish that, we’re bringing to market a compelling app offering at a price point that can be fully subsidized by the contractor. Offering a service with ongoing value, for a small upfront amount or for free to customers who just aren’t going to pay monthly for a membership, allows contractors to tap into a previously unreached persona.”

“This app offering should be purely additive without cannibalizing your existing membership sales,” Teekell added. “The convenience and loyalty reward features alone are enough to keep homeowners from looking elsewhere in the future. Keeping them off Google is a huge win!”

Strengthening the bond between contractors and homeowners has always been the sole focus for SmartAC.com. Traditionally, maintenance agreements have been the primary method for keeping customers engaged. However, with an average plan sign-up rate of 20%, the industry is ripe for a drastic change in the approach. Many leading contractors now offer multiple levels of service to allow homeowners to select a plan that suits them.

SmartAC.com anticipates its core offering will continue to make up a majority of its business. Fault detection from 24/7 remote visibility into HVAC and plumbing systems enables the best overall experience for homeowners, the longest operational life of equipment, and an extremely targeted approach to maximize the value created by a skilled workforce. Homeowners are seeing the value too, as the company has tracked a 97.8% annual retention rate on memberships powered by its platform.  

For more details on SmartAC.com’s “Connect” offering, visit their website at SmartAC.com or email partners@smartac.com.

About SmartAC.com

SmartAC.com is an innovative platform that uses wireless sensors and advanced software to monitor the health of HVAC and plumbing systems in real-time.  As the first Customer Loyalty Platform for the trades, the company’s mission is to help contractors nurture customer relationships remotely through technology-driven membership offerings. SmartAC.com helps contractors reduce the costs associated with servicing maintenance agreements, while providing homeowners with unrivaled value, convenience and peace of mind. 

Media Contact
Company Name: SmartAC.com
Contact Person: Kevin Lessard
Email: Send Email
Country: United States
Website: https://hvac.smartac.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: SmartAC.com Launches New App-Only Offering to Maximize Customer Retention

Bullous Keratopathy Market on Track for Major Expansion by 2034, According to DelveInsight | Aurion Biotechnologies, Emmecell, Cellusion, Trefoil Therapeutics,Price Vision Group

The Key Bullous Keratopathy Companies in the market include – Aurion Biotechnologies, Emmecell, Cellusion, Trefoil Therapeutics, Emmecell, Cellusion, Price Vision Group, and others.

 

DelveInsight’s “Bullous Keratopathy Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Bullous Keratopathy, historical and forecasted epidemiology as well as the Bullous Keratopathy market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

 

To Know in detail about the Bullous Keratopathy market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Bullous Keratopathy Market Forecast

 

Some of the key facts of the Bullous Keratopathy Market Report: 

  • The Bullous Keratopathy market size was valued ~USD 13.8 million in 2023 and is anticipated to grow with a significant CAGR during the study period (2020-2034)

  • In 2023, the market size for bullous keratopathy in the US was around USD 7.8 million and is expected to grow with the introduction of new therapies.

  • In 2023, the total market size for the EU4 and the UK was estimated at about USD 4.8 million, representing nearly 34% of the total market revenue for the 7MM.

  • In 2023, Germany had the largest market among the EU4 and the UK, with around USD 1.3 million, followed by France with about USD 1.1 million, and Italy with nearly USD 0.9 million.

  • In April 2024, Emmecell has successfully administered the final dose to the last patient in its Phase I trial in the US, which is assessing the safety and efficacy of EO2002 for corneal edema. A Phase III pivotal study is set to begin in the first quarter of 2025, positioning EO2002 as a potential groundbreaking treatment in this area.

  • In 2023, the total diagnosed prevalent cases of bullous keratopathy in the 7MM were around 192 thousand. This figure is anticipated to rise during the forecast period (2024–2034) due to an aging population and a higher frequency of ocular surgeries.

  • In 2023, the US represented about 41% of the total diagnosed prevalent cases of bullous keratopathy in the 7MM, while the EU4 and the UK together accounted for nearly 50% of cases, and Japan comprised approximately 9% of the total cases.

  • In 2023, the US had the highest number of diagnosed prevalent cases of bullous keratopathy in the 7MM, totaling around 79 thousand cases.

  • In 2023, Germany recorded the highest number of diagnosed prevalent cases of bullous keratopathy among the EU4 and the UK, with about 26 thousand cases, followed by France with nearly 22 thousand cases. In contrast, Spain had the lowest incidence, with around 14 thousand cases.

  • In 2023, Japan reported around 18 thousand diagnosed prevalent cases of bullous keratopathy, a figure anticipated to change during the forecast period.

  • In 2023, the diagnosed prevalent cases of bullous keratopathy in the US included around 30 thousand cases in males and approximately 48 thousand cases in females.

  • In 2023, about 39% of bullous keratopathy cases in the UK were male, while 61% were female.

  • In 2023, Japan recorded around 7 thousand male cases and 10 thousand female cases of bullous keratopathy, a number anticipated to change during the forecast period.

  • Key Bullous Keratopathy Companies: Aurion Biotechnologies, Emmecell, Cellusion, Trefoil Therapeutics, Emmecell, Cellusion, Price Vision Group, and others

  • Key Bullous Keratopathy Therapies: VYZNOVA (neltependocel), EO2002, CLS001, TTHX1114 (NM141), EO2002, CLS001, Fluorometholone, and others

  • The Bullous Keratopathy epidemiology based on gender analyzed that, females are more affected with Bullous keratopathy than males

  • The Bullous Keratopathy market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Bullous Keratopathy pipeline products will significantly revolutionize the Bullous Keratopathy market dynamics.

 

Bullous Keratopathy Overview

A general word used to describe any condition that affects the cornea is keratopathy. Bullouskeratopathy is one of several varieties of keratopathy, each with unique traits and causes. Bullous keratopathy causes corneal edoema and dysfunctional corneal endothelial cells as a result of fluid-filled blisters on the cornea.

 

Get a Free sample for the Bullous Keratopathy Market Report: 

https://www.delveinsight.com/report-store/bullous-keratopathy-market

 

Bullous Keratopathy Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

 

Bullous Keratopathy Epidemiology Segmentation:

The Bullous Keratopathy market report proffers epidemiological analysis for the study period 2020–2034 in the 7MM segmented into:

  • Total Prevalence of Bullous Keratopathy

  • Prevalent Cases of Bullous Keratopathy by severity

  • Gender-specific Prevalence of Bullous Keratopathy

  • Diagnosed Cases of Episodic and Chronic Bullous Keratopathy

 

Download the report to understand which factors are driving Bullous Keratopathy epidemiology trends @ Bullous Keratopathy Epidemiology Forecast

 

Bullous Keratopathy Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Bullous Keratopathy market or expected to get launched during the study period. The analysis covers Bullous Keratopathy market uptake by drugs, patient uptake by therapies, and sales of each drug. 

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Bullous Keratopathy Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

 

Bullous Keratopathy Therapies and Key Companies

  • VYZNOVA (neltependocel): Aurion Biotechnologies

  • EO2002: Emmecell

  • CLS001: Cellusion

  • TTHX1114 (NM141): Trefoil Therapeutics

  • EO2002: Emmecell

  • CLS001: Cellusion

  • Fluorometholone: Price Vision Group

 

Discover more about therapies set to grab major Bullous Keratopathy market share @ Bullous Keratopathy Treatment Market

 

Bullous Keratopathy Market Strengths

  • Advancements in understanding corneal endothelium function and epithelial cell regeneration have developed pharmacological and less invasive surgical techniques like DSAEK and DMEK.

  • The use of advanced diagnostic techniques like slit-lamp examination and ultrasound biomicroscopy has improved bullous keratopathy diagnosis

 

Bullous Keratopathy Market Opportunities

  • With no approved treatment in the US and EU, limited application of corneal transplant, and significant risk of rejections, there is a window of opportunity for pharma companies to develop pharmacological therapies.

  • Increasing research activities in the field of ophthalmology may lead to the exploration of different pathways involved in bullous keratopathy.

 

Scope of the Bullous Keratopathy Market Report

  • Study Period: 2020–2034

  • Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]

  • Key Bullous Keratopathy Companies: Aurion Biotechnologies, Emmecell, Cellusion, Trefoil Therapeutics, Emmecell, Cellusion, Price Vision Group, and others

  • Key Bullous Keratopathy Therapies: VYZNOVA (neltependocel), EO2002, CLS001, TTHX1114 (NM141), EO2002, CLS001, Fluorometholone, and others

  • Bullous Keratopathy Therapeutic Assessment: Bullous Keratopathy current marketed and Bullous Keratopathy emerging therapies

  • Bullous Keratopathy Market Dynamics: Bullous Keratopathy market drivers and Bullous Keratopathy market barriers 

  • Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies

  • Bullous Keratopathy Unmet Needs, KOL’s views, Analyst’s views, Bullous Keratopathy Market Access and Reimbursement 

 

To know more about Bullous Keratopathy companies working in the treatment market, visit @ Bullous Keratopathy Clinical Trials and Therapeutic Assessment

 

Table of Contents 

1. Bullous Keratopathy Market Report Introduction

2. Executive Summary for Bullous Keratopathy

3. SWOT analysis of Bullous Keratopathy

4. Bullous Keratopathy Patient Share (%) Overview at a Glance

5. Bullous Keratopathy Market Overview at a Glance

6. Bullous Keratopathy Disease Background and Overview

7. Bullous Keratopathy Epidemiology and Patient Population

8. Country-Specific Patient Population of Bullous Keratopathy 

9. Bullous Keratopathy Current Treatment and Medical Practices

10. Bullous Keratopathy Unmet Needs

11. Bullous Keratopathy Emerging Therapies

12. Bullous Keratopathy Market Outlook

13. Country-Wise Bullous Keratopathy Market Analysis (2020–2034)

14. Bullous Keratopathy Market Access and Reimbursement of Therapies

15. Bullous Keratopathy Market Drivers

16. Bullous Keratopathy Market Barriers

17.  Bullous Keratopathy Appendix

18. Bullous Keratopathy Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

 

 

About DelveInsight 

DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Bullous Keratopathy Market on Track for Major Expansion by 2034, According to DelveInsight | Aurion Biotechnologies, Emmecell, Cellusion, Trefoil Therapeutics,Price Vision Group

True Blue Tradie Marketing: Transforming the Way Aussie Tradies Generate Leads with Exclusive, High-Quality Clients

“True Blue Tradie Marketing offers exclusive, high-quality leads for Australian tradies, helping them grow their businesses without relying on third-party platforms or shared leads. Founded by tradie veteran Josh Kealy and marketing expert Ruby Hodgetts, the company provides a done-for-you lead generation system, covering over 25 trades. With a “no leads, no payment” guarantee, True Blue focuses on delivering ready-to-go clients directly to tradies. Visit truebluetradie.au”
Australian-Owned and Operated Lead Generation Service Offers Guaranteed Results for Tradies Seeking Business Growth through effective digital marketing strategies.

Sydney, Australia – Sep 30, 2024 – True Blue Tradie Marketing, a proudly Australian-owned and operated business, is revolutionizing how Aussie tradies grow their businesses by offering a unique, done-for-you lead generation system. With a laser focus on delivering exclusive, high-quality leads directly to tradies’ phones, True Blue Tradie Marketing is empowering Australian tradespeople to focus on their craft while leaving the marketing to the experts.

Why Tradies Are Turning to True Blue Tradie Marketing

In an increasingly competitive industry, many tradies find themselves caught in a cycle of chasing unreliable, inconsistent leads through third-party shared lead platforms or word-of-mouth referrals. The result? Wasted time, dwindling profits, and unsustainable business growth. True Blue Tradie Marketing provides a solution to this problem by delivering exclusive leads that eliminate the competition and ensure tradies receive the job inquiries they really want.

“We understand how tough it can be for tradies to grow their businesses while managing their trade,” said Josh Kealy, Co-Founder of True Blue Tradie Marketing and a former tradie with over 15 years of hands-on experience. “That’s why we’ve built a system designed to take the stress out of finding new clients, so tradies can focus on what they do best — delivering top-notch services.”

Exclusive Leads — Delivered Directly to You

Unlike traditional lead generation services that force tradies to compete for the same clients, True Blue Tradie Marketing ensures every lead is 100% exclusive. This means no more shared leads, no more low-quality inquiries, and no more wasted time chasing irrelevant jobs.

“We’re all about quality over quantity,” says Ruby Hodgetts, Co-Founder and digital marketing expert with nearly a decade of experience. “Our leads are exclusive, high-quality, and tailored to the specific trade. We make sure our clients get calls from people who are serious about hiring a professional, which means more high-paying jobs and better business growth.”

Proven Success Across a Range of Trades

True Blue Tradie Marketing specializes in generating leads for over 25 different trades, including:

  • Tree Services & Arborists
  • Bathroom & Kitchen Remodeling
  • HVAC (Heating, Ventilation, and Air Conditioning)
  • Plumbing, Electrical, and Solar Services
  • Deck Building, Concreting, and Epoxy Flooring
  • Roofing, Asbestos Removal, Mould Remediation, and more

This broad industry focus ensures tradies from diverse sectors benefit from consistent, reliable leads that match their expertise.

Built by Aussies for Aussies: A Unique Blend of Expertise

True Blue Tradie Marketing was founded by Josh Kealy and Ruby Hodgetts, who bring a perfect mix of on-the-ground trade experience and cutting-edge digital marketing skills to the table. Josh’s deep understanding of the trades industry, combined with Ruby’s marketing acumen, has resulted in a powerful system that delivers real, tangible growth for Australian service-based businesses.

“Our approach isn’t just about getting leads — it’s about getting the right leads,” says Kealy. “We know the Aussie market inside and out, and our campaigns are customized for the unique needs of tradies. That’s what makes us different.”

The True Blue Difference: Why Tradies Trust Us

True Blue Tradie Marketing stands apart from the crowd by offering a range of benefits that directly address the pain points of tradies:

  • Exclusive, High-Quality Leads: Tradies receive leads that are tailored to their trade — no sharing with competitors.
  • Guaranteed Results: No leads, no payment. If clients don’t get leads, they don’t pay. It’s that simple.
  • Done-for-You Marketing: From start to finish, True Blue handles all marketing efforts so tradies can focus on their work.
  • Australian Expertise: As an Australian-owned company, True Blue Tradie Marketing understands the local market and the challenges Australian tradies face.
  • True Blue Values: Built on the principles of quality, honesty, and integrity, True Blue Tradie Marketing guarantees transparency and delivers on promises.


Results That Speak for Themselves

Since launching, True Blue Tradie Marketing has seen significant success for its clients, with many tradies experiencing fuller schedules, better-paying jobs, and steady business growth.

“Since signing up with True Blue Tradie Marketing, we’ve been able to secure consistent high-quality leads without having to waste time on low-value inquiries,” says John, an HVAC contractor from Melbourne. “It’s really helped us fill our pipeline and focus on doing great work instead of constantly searching for clients.” True Blue Tradie Marketing now generates over 6000 calls per month for their clients around Australia. “Things have been going absolutely crazy and our clients just cant get enough of the leads we are sending them,” says Kealy.

The Cost of Doing Nothing

In today’s competitive market, relying on old-school methods like shared lead platforms, local directories, or word-of-mouth referrals is no longer enough. Without a reliable source of exclusive, high-paying jobs, tradies risk falling behind their competitors and seeing shrinking profit margins.

Ruby Hodgetts warns, “The cost of doing nothing is too high. If tradies don’t adapt and take control of their lead generation, they risk missing out on opportunities that could grow their business exponentially.”

What’s Next for Tradies?

True Blue Tradie Marketing is actively welcoming new tradies who are ready to take their businesses to the next level. Whether you’re an electrician, plumber, roofer, or auto mechanic, True Blue Tradie Marketing has the solution to your lead generation challenges.

“We’re on a mission to help Aussie tradies work smarter, not harder,” says Kealy. “Our leads are pre-qualified, high-paying, and ready to go — so tradies can focus on their craft and grow their business without the stress.”

Contact True Blue Tradie Marketing Today

To learn more about how True Blue Tradie Marketing can help your business grow with exclusive, high-quality leads, visit truebluetradie.au or call (02) 5850 2171 to speak directly with the team.

About True Blue Tradie Marketing

True Blue Tradie Marketing is an Australian-owned lead generation company specializing in exclusive, high-quality leads for tradies across a range of industries. Founded by former tradie Josh Kealy and digital marketing expert Ruby Hodgetts, True Blue Tradie Marketing combines insider industry knowledge with proven marketing strategies to help Australian service-based businesses succeed.

For media inquiries, please contact:

Josh Kealy

Co-Founder, True Blue Tradie Marketing

Phone: (02) 5850 2171

Email: info@truebluetradie.au

Website: www.truebluetradie.au

Media Contact
Company Name: True Blue Tradie Marketing
Contact Person: Joshua Kealy
Email: Send Email
Country: Australia
Website: https://truebluetradie.au

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: True Blue Tradie Marketing: Transforming the Way Aussie Tradies Generate Leads with Exclusive, High-Quality Clients

Preferred Construction LLC: Knoxville’s Trusted Name in Home Remodeling

Preferred Construction LLC is Knoxville’s leading home remodeling contractor, specializing in kitchen and bathroom renovations, full home remodels, and custom decks. Known for exceptional workmanship and client satisfaction, the team collaborates closely with homeowners to bring their visions to life. Owner Tim J. Shaughnessy and his experienced team prioritize quality, ensuring projects are completed on time and within budget.

Preferred Construction, Knoxville’s leading home remodeling contractor, is proud to offer a renewed emphasis on excellence in workmanship and client satisfaction for every home remodel. The company has built a reputation as the trusted brand in home renovation across the area by turning ordinary houses into dream homes.

For years, Preferred Construction has been a household name in the industry. The company provides an array of services in Knoxville and its surrounding areas, ranging from kitchen and bathroom remodels to full home renovations and custom deck installations. Their commitment to top-quality workmanship and personalized attention to homeowners has established them as a leader in the construction industry.

Why Choose Preferred Construction?

Homeowners have learned to rely on Preferred Construction for its unwavering commitment to excellence. The team works closely with clients from initial consultation to project completion; every detail is meticulously planned and executed. Whether it’s a minor update or a full-scale renovation, Preferred Construction strives to exceed expectations by creating spaces that reflect homeowners’ style, needs, and vision.

It has been my entrepreneurial spirit and vast experience in luxury home finishes and business development that shape my vision for Preferred Construction. From spearheading the right start-ups to driving successful business operations, my leadership ensures there is an unwavering focus on quality and innovation in everything we do,” says Tim J. Shaughnessy, Owner of Preferred Construction. “Together, Barb and I bring decades of experience in renovation and remodeling, and we take pride in transforming homes with craftsmanship that endures.”

Specializing in a Wide Range of Home Remodeling Services

Preferred Construction offers a broad spectrum of home remodeling services in Knoxville, including:

  • Kitchen Renovation: Upgrade your kitchen’s look and functionality with state-of-the-art designs, efficient layouts, and cutting-edge appliances.

  • Bathroom Remodels: Transform your bathroom into the epitome of elegance with exclusive fixtures, exquisite designs, and practical functions.

  • Custom Deck Builders: Give your exterior space a stylish makeover with magnificent decks designed for entertainment and relaxation.

  • Full House Renovation: Imagine, design, and build top-to-bottom changes that make your space more functional, comfortable, and stylish.

No project is too big or too small for the team at Preferred Construction. Each client’s vision is brought to life while ensuring that workmanship and customer care remain at the highest level.

A Commitment to Customer Satisfaction

Preferred Construction places a strong emphasis on the customer experience. The company’s approach to every project ensures completion on time, within budget, and with attention to detail. The team consistently delivers on its promises, maintaining transparency and open communication, which sets them apart from other remodeling contractors in the Knoxville area.

About Preferred Construction

Preferred Construction is one of the top locally owned and operated home remodeling firms, situated in Knoxville, Tennessee. The company has become well-known in the home remodeling industry, handling everything from kitchen and bathroom renovations to whole-house makeovers and custom deck building. It has a stellar reputation for superb craftsmanship and individualized service. The mission of Preferred Construction is to provide every client with a home they love, built to their exact specifications.

For more information about Preferred Construction or to schedule a consultation, visit www.preferredconstructiontn.com.

Media Contact
Company Name: Preferred Construction LLC – Home Remodeling Contractors Knoxville
Contact Person: Tim Shaughnessy
Email: Send Email
Phone: 865-309-5180
City: Knoxville
State: Tennessee
Country: United States
Website: https://preferredconstructiontn.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Preferred Construction LLC: Knoxville’s Trusted Name in Home Remodeling